After Medicare sweetened payments for simple office-based endoscopic procedures, doctors in one New York City practice performed many more in-office bladder biopsies, but the volume of hospital procedures stayed roughly the same, a new study finds.

Amgen Inc. received a boost recently when the company announced positive results from a pivotal head-to-head phase III study that was conducted with Amgen's main pipeline candidate, denosumab.

Main Category: Prostate / Prostate Cancer Also Included In: Bones / Orthopaedics Pharma Industry / Biotech Industry Amgen announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints.

Traditional Chinese medicine has been around for thousands of years. It might sound exotic, but odds are you know something about these therapies.

Known as PKN-3, the target is a protein kinase C-related molecule that is believed to play an important role in the growth of cancer cells, as well as metastasis formation.

Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on a series of novel compounds that simultaneously blocked two critical pathways involved in the growth and survival of cancer cells.

A recent breakthrough by Finnish researches has led to a new breast cancer treatment.

Experts call for integrating treatment centres for formulating national policy Friday, February 05, 2010 Our correspondent Islamabad Health experts have stressed on the need for integrating all cancer treatment centres and oncology, pathology and radiotherapy departments of hospitals to share cancer related data with one another, which could be ...

The American Society for Radiation Oncology and the American College of Radiology have released practice guidelines for image guided radiation therapy and stereotactic body radiation therapy in the February issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.

Nine years ago this month, Allan Rock - then the federal health minister - was operated on for prostate cancer.

MANCHESTER, England & NEW YORK-- --Pfizer Inc. and DxS today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 , an immunotherapy vaccine in development for the treatment of glioblastoma multiforme .

CanLiv: The Hepatobiliary Cancers Foundation in partnership with The Cholangiocarcinoma Foundation will host the 1st Annual Biliary Tract-Gallbladder Cancer Research Symposium on Friday, May 7, 2010 at the American Society of Clinical Oncologists headquarters in Alexandria, Virginia.

The drug pazopanib slowed the progression of advanced renal cell carcinoma , a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology .

Friday, February 05, 2010 Jamila Achakzai Islamabad Avoidance and cessation of tobacco use can potentially reduce the lung cancer incidence and mortality by around 90 per cent, said Shifa International Hospital's Medical Oncologist Dr Kamran Rasheed at a World Cancer Day function here Thursday.

Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on innovative oncology therapies, today announced that Ronald A. Martell has been appointed to the position of chief executive officer, succeeding Jerry McMahon, Ph.D., who will remain as non-executive chairman of the Board of Directors.

Changes to Medicare, the U.S. federal health plan for the elderly, may be damaging important aspects of cancer care in the United States, according to a study released on Thursday.

For 54-year-old Sharda Sethi, who was detected with breast cancer last year, life couldn't be more unfair.

A sexually-transmitted disease may be the miracle some cancer patients have been hoping for.

Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive.

PHILADELPHIA The Food and Drug Administration has given an additional approval to a breast cancer drug made by GlaxoSmithKline, GSK announced Friday.